Key Statistics for HIK
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M GBP)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (USD)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HIK
- Net Income (M/USD)
Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on developing, manufacturing, and marketing a range of both branded and non-branded generic and in-licensed pharmaceutical products. The Company's operations are conducted in the United States, the Middle East, and North Africa region, as well as Europe.
More Company Profile & Key Executives for HIK
|Mazen Samih Taleb DarwazahVice Chairman/CEO:MENA||Said Sameeh Talib DarwazahChief Executive Officer|
|Khalid NabilsiChief Financial Officer||Michael Raya "Mike"President & CEO:US|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries